# Phase 1 Study to Characterize the Safety and Pharmacokinetics of Single Intravenous Dose of Lorazepam in Healthy Japanese Adult Subjects

> **NCT01994668** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 8 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Lorazepam
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01994668
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2014-02
- **Final completion:** 2014-02
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2014-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01994668

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01994668, "Phase 1 Study to Characterize the Safety and Pharmacokinetics of Single Intravenous Dose of Lorazepam in Healthy Japanese Adult Subjects". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01994668. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*